We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$840M
AUM Growth
+$124M
Cap. Flow
+$111M
Cap. Flow %
13.21%
Top 10 Hldgs %
40.57%
Holding
336
New
86
Increased
109
Reduced
60
Closed
39

Sector Composition

Rank Sector Weight
1 Technology 7.45%
2 Healthcare 7.07%
3 Industrials 4.36%
4 Financials 4.13%
5 Communication Services 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXT icon
76
Crane NXT
CXT
$2.94B
$2.45M 0.29%
124,307
+280
+0.2% +$5.46K
LEA icon
77
Lear
LEA
$7.15B
$2.42M 0.29%
23,821
-456
-2% -$51.3K
USB icon
78
US Bancorp
USB
$99.2B
$2.42M 0.29%
60,038
+52,620
+709% +$2.19M
VFC icon
79
VF Corp
VFC
$6.63B
$2.42M 0.29%
+41,795
New +$2.47M
CVS icon
80
CVS Health
CVS
$141B
$2.42M 0.29%
+25,231
New +$2.51M
TWX
81
DELISTED
Time Warner Inc
TWX
$2.41M 0.29%
+32,819
New +$2.43M
IVW icon
82
iShares S&P 500 Growth ETF
IVW
$74.4B
$2.41M 0.29%
+82,680
New +$2.4M
MRK icon
83
Merck
MRK
$312B
$2.38M 0.28%
43,195
+37,664
+681% +$2M
NTGR icon
84
NETGEAR
NTGR
$650M
$2.37M 0.28%
49,868
+1,493
+3% +$64.2K
ICF icon
85
iShares Select U.S. REIT ETF
ICF
$2.09B
$2.35M 0.28%
43,420
+4,590
+12% +$236K
FLEX icon
86
Flex
FLEX
$46.7B
$2.34M 0.28%
263,642
-6,469
-2% -$60.3K
TMO icon
87
Thermo Fisher Scientific
TMO
$195B
$2.34M 0.28%
+15,854
New +$2.34M
ALL icon
88
Allstate
ALL
$64.8B
$2.33M 0.28%
33,364
-1,575
-5% -$105K
GILD icon
89
Gilead Sciences
GILD
$162B
$2.32M 0.28%
27,769
+24,110
+659% +$2.14M
MGLN
90
DELISTED
Magellan Health Services, Inc.
MGLN
$2.28M 0.27%
34,673
+48
+0.1% +$3.23K
IGF icon
91
iShares Global Infrastructure ETF
IGF
$10.8B
$2.26M 0.27%
55,955
-590
-1% -$23.4K
TSM icon
92
TSMC
TSM
$2.2T
$2.24M 0.27%
85,553
+553
+0.7% +$13.8K
NICE icon
93
Nice
NICE
$5.52B
$2.24M 0.27%
35,129
+99
+0.3% +$6.29K
LDOS icon
94
Leidos
LDOS
$13.2B
$2.19M 0.26%
45,837
-571
-1% -$28.2K
SCHX icon
95
Schwab US Large- Cap ETF
SCHX
$71.8B
$2.19M 0.26%
263,742
+2,310
+0.9% +$19K
TARO
96
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2.19M 0.26%
+15,020
New +$2.13M
DHR icon
97
Danaher
DHR
$127B
$2.18M 0.26%
32,097
+22,262
+226% +$1.46M
NXPI icon
98
NXP Semiconductors
NXPI
$69B
$2.16M 0.26%
+27,522
New +$2.36M
EZA icon
99
iShares MSCI South Africa ETF
EZA
$536M
$2.1M 0.25%
39,750
-2,100
-5% -$109K
CIB icon
100
Grupo Cibest SA
CIB
$19.8B
$2.09M 0.25%
59,854
+279
+0.5% +$9.88K

Similar funds

Bailard's Q2 2016 Portfolio in Review

As of Q2 2016, Bailard held 336 positions worth $840M, up 17% from $717M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Bailard deployed $111M of net new capital in Q2 2016, opening 86 new positions and adding to 109 existing holdings. Its largest new stake was iShares Intermediate Government/Credit Bond ETF: 80,477 shares worth $9.12M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was SPDR Gold Trust, an estimated $53.1M trimmed.

  • Bailard's largest Q2 2016 buy was iShares Intermediate Government/Credit Bond ETF: 80,477 shares worth $9.12M.
  • Bailard added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $51.2M increase.
  • Bailard's biggest Q2 2016 reduction was SPDR Gold Trust, cutting an estimated $53.1M.
  • Bailard fully exited iShares 1-3 Year Treasury Bond ETF in Q2 2016, selling an estimated $56.2M.
  • Bailard's ten largest holdings make up 41% of its $840M portfolio in Q2 2016.
  • Bailard opened 86 new positions and closed 39 in Q2 2016.
  • Bailard's portfolio value rose 17% quarter-over-quarter to $840M.

Based on Bailard's 13F filing for Q2 2016, filed 8 Aug 2016.